3Levine AJ Perry ME, Chang A,et al. The 1993 Waher Hubert Lecture: the role of lhe p53 turnout-suppressor gene in tumorigenesis [J]. Br J Cancer, 1994,69 ( 3 ) :409 - 416.
4Pestereli HE, Ogus M, Oren N ,et al. Bcl-2 and p53 expression in insular and in well-differentiated lhyroid carcinomas with an insular patlern [J]. Endocr Palhol,2001,12( 3 ) :301 - 305.
5Ferenc T, Lewinski A, Lange D, et al. Analysis of p53 and P21 WAFI proteins expression in lollicular thyroid tumors[ J]. Pol J Patho ,2004.55(4) :133 - 141.
6Nikiforov YE. Genetic alterations involved in the transition from well differentiated to poorly differentiated and anaplastie thyroid carcinomas [J]. Endoer Palhol,2004,15 ( 4 ) : 319 - 327.
7Quiros RM, Ding HG, Gattuso P,et al. Evidence that one subset of anaplastic thyroid carcinomas derived from papillary carcinomas due to BRAF and p53 mutations [J]. Cancer,2005, 103( 11 ) :2261 -2268.
8Malaguarnera R, Vella V, Vigneri R, et al. p53 family proteins in thyroid cancer [J].Endocr Relat Cancer,2007,14( 1 ) :43 -60.
9Olivier M, Eeles R, Hollslein M,et al. The IARC TP53 database:new online mulation analysis and recommendations to users [J]. Hum Mutat,2002,19(6) :607 -614.
10Nagayama Y, Yokoi H, Takeda K, et al. Adenovirus-mediated tumor suppressor 1)53 gene therapy for anaplastic thyroid carcinoma in vitro and in vivo [ J ]. J Clin Endoerinol Metab, 2000,85( 11 ) :4081 -4086.
2STIER CB,RICCABONA G,TOTSCH M,et al.Incidence and clinical characteristics of thyroid carcinoma after iodine prophylaxis in an endemic goiter country[J].Thyroid,1997,7(5):733 -741.
3KOLONEL LN,HANKIN JH,WILKENS LR,et al.An epidemiologic study of thyroid cancer in Hawaii[J].Cancer Causes Control,1990,1(3):223 -234.
4FRANCESCHI S,TALAMINI R,FASSINA A,et al.Diet and epithelial cancer of thyroid gland[J].Tumori,1990,76 (4):331 -338.
5LIND P,LANGSTEGER W,MOLNAR M,et al.Epidemiology of thyroid diseases in iodine sufficiency[J].Thyroid,1998,8 (12):1179-1183.
6Wantanabe T,Nakamura M,Yonekawa Y,et al.Promoter hypermethylation and homozygous deletion of the p19ARF and p16INK4a genes in oligodendrogliomas[J].Act Neuropathol,2001,101 (3):185.
7Herman JG,Graff JR,Baylin SB,et al.Methylation-specific PCR:A novel PCR assay for methylation status of CpG islands[J].Proc Natl Acad Sci USA,1996,93:9821～9826.
8Jones PA,Laird PW.Cancer epigenetics comes of age[J].Nat Genet,1999,21 (2):163～167.
9Rocco J W,Sidransky D.p16 (MTS-I/CDKN2/INK4a)in cancer progression[J].Exp Cell Res,2001,264(1):42～45.
10Esteller M,Com PG,Baylin SB,et al.A gene hypermethylation profile of human cancer[J].Cancer Res,2001,61:3225 ～3229.
2Doney, P. M. and Cannon, J. P. (1997)'An examination of the nature of trust inbuyer seller relationships', Journal of Marketing, Vol.61, No. 2, pp. 35-51
3Berry, L. L. (1983) ‘Relationship Marketing', In: Emerging Perspectives of Services Marketing(Eds)Berry, L. L., et al (Chicago),American Marketing Association
